Duque denies not acting quickly enough on Pfizer vaccine | Inquirer News

Duque denies not acting quickly enough on Pfizer vaccine

/ 02:47 PM December 17, 2020

DOH Secretary Francisco Duque III

DOH Secretary Francisco Duque. FILE PHOTO

MANILA, Philippines — Health Secretary Francisco Duque III denied on Thursday that he did not act quick enough in signing the Confidentiality Disclosure Agreement (CDA) between the Department of Health and US drugmaker Pfizer as alleged by Senator Panfilo Lacson.

“I have the chronology of events so that this is all documented and there is no such a thing that I did not act quick enough,” he said in an interview over ABS-CBN News Channel.

Article continues after this advertisement

“The thing is you go through a process, and when you go through a process, you cannot just be hurrying up things just like that. You have to be prudent and cautious especially because you are talking about a brand new, novel vaccine at that,” he added.

FEATURED STORIES

Duque was reacting to the earlier statement of Lacson, who said that Duque’s indifference was to blame for failing to work on the necessary documentation for the deal with Pfizer.

“They could have secured the delivery of 10 million Pfizer vaccines as early as January next year, way ahead of Singapore but for the indifference of Sec. Duque failed to work on the necessary documentary requirement namely, the Confidentiality Disclosure Agreement (CDA) as he should have done,” Lacson earlier said.

Article continues after this advertisement

Duque, however, explained that it was only on September 24 that the DOH was informed that instead of the Department of Science of Technology, the DOH would be the agency to sign the deal with Pfizer. He said the order came from the Office of the Executive Secretary.

Article continues after this advertisement

“As a medical professional, my overriding principle in my practice of medicine is always to err on the side of caution, so I really needed to make sure that the concerned offices would clear the CDA document that was by the way only submitted [by Pfizer] on August 11,” said Duque.

Article continues after this advertisement

“And up to that, that CDA was in fact intended to be signed per Pfizer request by the Office of the President, the Executive Secretary being the representative,” he added.

“That would have spared Pfizer from signing a confidentiality agreement with many other government agencies so isa na lang dapat (there should have been only one signatory),” he further explained.

Article continues after this advertisement

However, Duque said there were “alterations” made and the legal departments of the DOST, Office of the Executive Secretary, and the DOH had to “clear the provisions of the non-disclosure agreement and we had to make sure that the provisions were not onerous or disadvantageous to the DOH and government.”

CFC

RELATED STORY:

No Pfizer guarantee of 10 million doses of COVID-19 vaccine for PH – Duque

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: coronavirus Philippines, COVID-19, COVID-19 Vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.